The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens

Eur J Med Chem. 2020 Mar 15:190:112132. doi: 10.1016/j.ejmech.2020.112132. Epub 2020 Feb 8.

Abstract

Cystic fibrosis is a rare genetic disease characterized by the production of dehydrated mucus in the lung able to trap bacteria and rendering their proliferation particularly dangerous, thus leading to chronic infections. Among these bacteria, Staphylococcus aureus and Pseudomonas aeruginosa play a major role while, within emerging pathogens, Stenotrophomonas maltophilia, Achromobacter xylosoxidans, Burkholderia cepacia complex species, as well as non-tuberculous mycobacteria are listed. Since a common feature of these bacteria is the high level of drug resistance, cell division, and in particular FtsZ, has been explored as a novel therapeutic target for the design of new molecules with antibacterial properties. This review summarizes and provides insight into recent advances in the discovery of compounds targeting FtsZ: the majority of them exhibit anti-staphylococcal activity, while a few were directed against the cystic fibrosis Gram negative pathogens.

Keywords: Antibiotic resistance; Cell division; Cystic fibrosis; FtsZ; Microbial infections.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / antagonists & inhibitors*
  • Cystic Fibrosis / microbiology
  • Cytoskeletal Proteins / antagonists & inhibitors*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • GTP Phosphohydrolases / antagonists & inhibitors
  • Gram-Negative Bacteria / drug effects
  • Humans
  • Staphylococcal Infections / drug therapy
  • Staphylococcus aureus / drug effects

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Cytoskeletal Proteins
  • Enzyme Inhibitors
  • FtsZ protein, Bacteria
  • GTP Phosphohydrolases